Provided by Tiger Trade Technology Pte. Ltd.

Creative Medical Technology Holdings, Inc.

1.93
+0.15008.43%
Post-market: 1.930.00000.00%16:43 EST
Volume:37.49K
Turnover:71.04K
Market Cap:6.74M
PE:-0.69
High:1.98
Open:1.86
Low:1.80
Close:1.78
52wk High:6.90
52wk Low:1.50
Shares:3.49M
Float Shares:3.23M
Volume Ratio:1.42
T/O Rate:1.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.7890
EPS(LYR):-3.7108
ROE:-98.14%
ROA:-59.68%
PB:1.21
PE(LYR):-0.52

Loading ...

Creative Medical Technology Reports Positive Interim Results for CELZ-201 in Chronic Lower Back Pain Trial

Reuters
·
Jan 13

Creative Medical Technology Holdings Reaches Major Clinical Inflection Point With Positive Interim Data From Adapt Trial and Celz-201 (Olastrocel) in the Treatment of Chronic Lower Back Pain

THOMSON REUTERS
·
Jan 13

Creative Medical Technology Holdings Secures Regulatory Approval for Burn Pit Initiative

Reuters
·
Jan 06

Creative Medical Technology Holdings Inc. Held Annual Shareholder Meeting

Reuters
·
Dec 20, 2025

BRIEF-Creative Medical Technology Completes Enrollment In FDA-Cleared Adapt Trial

Reuters
·
Dec 17, 2025

Creative Medical Technology Holdings Completes Enrollment in FDA-Cleared CELZ-201 Trial

Reuters
·
Dec 17, 2025

Creative Medical Technology Holdings, Inc. Completes Enrollment in FDA-Cleared Adapt Trial for Celz-201-Olastrocel, Marking Major Clinical Inflection Point

THOMSON REUTERS
·
Dec 17, 2025

BRIEF-Creative Medical Technology Holdings Announces World Health Organization Approval Of “Olastrocel”

Reuters
·
Dec 02, 2025

Creative Medical Technology Holdings Announces World Health Organization Approval of “Olastrocel” as Inn for Lead Allogeneic Cell Therapy Celz-201

THOMSON REUTERS
·
Dec 02, 2025

Creative Medical Technology Holdings Awards CEO $100,000 Bonus and CFO $25,000 Bonus

Reuters
·
Nov 12, 2025

Creative Medical Technology Holdings Inc expected to post a loss of 48 cents a share - Earnings Preview

Reuters
·
Nov 05, 2025

Creative Medical Technology Holdings Raises $4.2 Million Through Warrant Exercises and Issues New Warrants

Reuters
·
Nov 01, 2025

Creative Medical Technology Holdings, Inc. Ignites Next-Gen Regenerative BioDefense Initiative for U.S. Veterans Exposed to Burn Pits

GlobeNewswire
·
Oct 30, 2025

Creative Medical Technology Holdings Inc. Announces Date for Annual Stockholders Meeting

Reuters
·
Oct 30, 2025

Creative Medical announces agreements for warrant exercise for $4.2M proceeds

TIPRANKS
·
Oct 29, 2025

Press Release: Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $4.2 Million Gross Proceeds

Dow Jones
·
Oct 29, 2025

Creative Medical Technology Holdings Issues Letter to Shareholders

GlobeNewswire
·
Oct 27, 2025

Creative Medical Technology Holdings Congratulates 2025 Nobel Laureates for Regulatory T Cell Breakthroughs

GlobeNewswire
·
Oct 07, 2025

Creative Medical Technology Holdings Secures FDA Fast Track Designation for CELZ-201-DDT - Advancing Breakthrough Therapy for Chronic Lower Back Pain

GlobeNewswire
·
Aug 13, 2025

Creative Medical Technology Holdings Inc expected to post a loss of 63 cents a share - Earnings Preview

Reuters
·
Aug 06, 2025